PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Screening for matrix effect in leukemia subtypes could sharpen chemotherapy targeting

2014-12-05
(Press-News.org) Location, location, location goes the old real estate proverb but cancer also responds to its neighborhood, particularly in the physical surroundings of bone marrow cells where human myeloid leukemias arise and where, according to two Harvard bioengineers, stiffness in the surrounding extracellular matrix (ECM) can predict how cancer subtypes react to chemotherapy. Correcting for the matrix effect could give oncologists a new tool for matching drugs to patients, the researchers say.

In work to be presented at the ASCB/IFCB meeting in Philadelphia, Jae-Won Shin and David Mooney of Harvard University's Wyss Institute for Biologically Inspired Engineering in Cambridge, MA, describe building a three-dimensional (3D) hydrogel system with tunable stiffness to see how relative stiffness of the surrounding ECM affected the resistance of human myeloid leukemias to chemotherapeutic drugs. They found, for example, that chronic myeloid leukemias (CML) grown in their viscous 3D gel system were more resistant to a widely used cancer drug, Imatinib (Gleevec), than those cultured in a rigid matrix. Using this and other data from their variable ECM system, the researchers screened libraries of small molecule drugs, identifying a subset of drugs they say will be more likely to be effective against CML, regardless of the surrounding matrix. By correcting for the matrix effect, Shin and Mooney believe their novel approach to drug screening could more precisely tailor chemotherapy to a patient's individual blood cancer type.

Though leukemia is relatively rare, it is the sixth leading cause of cancer death in the U.S. and is notoriously resistant to therapy. Patients usually undergo multiple courses of chemotherapy in hopes of eliminating all of the cancer cells. Part of the difficulty in targeting drugs is that proliferating cancer cells of all types are known to shape and be shaped by their physical neighbors. In myeloid leukemias, which start in blood precursor cells in the bone marrow, the cancer's growth radically alters the composition of its ECM including fluids, molecules, and fibers. Uncontrolled deposition of collagen in the ECM, for examples, is a telltale sign of certain leukemias. While myeloid leukemia subtypes are defined by distinct genetic mutations and the activation of known signaling pathways, the Harvard bioengineers looked to see if changes in matrix stiffness played a part in cancer cell proliferation and if myeloid leukemia subtypes could be sorted out by their responses.

Cancer cells are not two-dimensional and the recent development of 3D culturing systems has changed our views of how many types of cancer progress in three-dimensional human tissues. Shin and Mooney's 3D hydrogel system allowed them to vary the stiffness of the matrix and uncover different growth patterns, which they used to profile different leukemia subtypes. They also looked at a cellular signaling pathway, Protein Kinase B (AKT), known to be involved in mechanotransduction and thus sensitive to stiffness in different leukemia subtypes. They discovered that CML cells in the 3D hydrogel were resistant to an AKT inhibitor while AML cells grown in the same conditions were responsive to the drug, supporting their idea that a tunable matrix system could be a way to sort out subtypes by drug resistance.

INFORMATION:

Extracellular matrix mechanics causes systematic variation in cancer cell proliferation and responses to drugs against myeloid leukemias J. Shin1,2, D.J. Mooney1,2;
1School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, 2The Wyss Institute for Biologically Inspired Engineering, Boston, MA

Contact: Jae-Won Shin, PhD, jwshin@seas.harvard.edu

Author presents at ASCB: Poster Session: Cancer Therapy 1
Sunday, December 7
Board 429
Post 294
Time: 12:00 to 1:30 pm

Media Contacts: John Fleischman
jfleischman@ascb.org
513.706-0212 (mobile)

Carol Blymire
carol@carolblymire.com
301.332.8090 (mobile)



ELSE PRESS RELEASES FROM THIS DATE:

Rescuing the Golgi puts brakes on Alzheimer's progression

2014-12-05
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang ...

Gravity: It's the law, even for cells

Gravity: Its the law, even for cells
2014-12-05
VIDEO: Nucleoli (green), small liquid-like nuclear bodies, are kept small and afloat by a fine actin mesh. When the mesh breaks, the nucleoli quickly being to fall and coalesce into larger... Click here for more information. Everybody knows that cells are microscopic, but why? Why aren't cells bigger? The average animal cell is 10 microns across and the traditional explanation has been cells are the perfect size because if they were any bigger it would be difficult to get enough ...

Light switchable proteins and superresolution reveal moving protein complexes

2014-12-05
Cells are restless. They move during embryogenesis, tissue repair, regeneration, chemotaxis. Even in disease, tumor metastasis, cells get around. To do this, they have to keep reorganizing their cytoskeleton, removing pieces from one end of a microtubule and adding them to the front, like a railroad with a limited supply of tracks. The EB family of proteins helps regulate this process and can act as a scaffold for other proteins involved in pushing the microtubule chain forward. Still, how these EB proteins function in space and time has remained a mystery. Now Peng ...

The antioxidant capacity of orange juice is multiplied tenfold

The antioxidant capacity of orange juice is multiplied tenfold
2014-12-05
The antioxidant activity of citrus juices and other foods is undervalued. A new technique developed by researchers from the University of Granada for measuring this property generates values that are ten times higher than those indicated by current analysis methods. The results suggest that tables on the antioxidant capacities of food products that dieticians and health authorities use must be revised. Orange juice and juices from other citrus fruits are considered healthy due to their high content of antioxidants, which help to reduce harmful free radicals in our body, ...

Penicillin tactics revealed

2014-12-05
Penicillin, the wonder drug discovered in 1928, works in ways that are still mysterious almost a century later. One of the oldest and most widely used antibiotics, it attacks enzymes that build the bacterial cell wall, a mesh that surrounds the bacterial membrane and gives the cells their integrity and shape. Once that wall is breached, bacteria die -- allowing us to recover from infection. That would be the end of the story, if resistance to penicillin and other antibiotics hadn't emerged over recent decades as a serious threat to human health. While scientists continue ...

Stick out your tongue

2014-12-05
Physicians often ask their patients to "Please stick out your tongue". The tongue can betray signs of illness, which combined with other symptoms such as a cough, fever, presence of jaundice, headache or bowel habits, can help the physician offer a diagnosis. For people in remote areas who do not have ready access to a physician, a new diagnostic system is reported in the International Journal of Biomedical Engineering and Technology that works to combine the soft inputs of described symptoms with a digital analysis of an image of the patient's tongue. Karthik Ramamurthy ...

IRCM researchers identify a protein that controls the 'guardian of the genome'

2014-12-05
Montréal, December 5, 2014 - A new study published in the scientific journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) sheds new light on a well-known mechanism required for the immune response. Researchers at the IRCM, led by Tarik Möröy, PhD, identified a protein that controls the activity of the p53 tumour suppressor protein known as the "guardian of the genome". The researchers study the development of T cells and B cells, which are lymphocytes (or immune cells) that play a central role in protecting our ...

Drugs in the environment affect plant growth

2014-12-05
The drugs we release into the environment are likely to have a significant impact on plant growth, a new study has revelealed. By assessing the impacts of a range of non-steroidal anti-inflammatory drugs, researchers at the University of Exeter Medical School and Plymouth University have shown that the growth of edible crops can be affected by these chemicals - even at the very low concentrations found in the environment. Published in the Journal of Ecotoxicology and Environmental Safety, the research focused its analysis on lettuce and radish plants and tested the ...

Salience network is linked to brain disorders

2014-12-05
CORAL GABLES, Fla (December 4, 2014) -- How does the brain determine what matters? According to a new scientific article, a brain structure called the insula is essential for selecting things out of the environment that are "salient" for an individual, and dysfunction of this system is linked to brain disorders such as autism, psychosis and dementia. In psychology and neuroscience, the term "salient" is used to describe a thing, person, place or event that stands out, or that is set apart from others. The current article, published online by Nature Reviews Neuroscience ...

Apixaban in DVT and pulmonary embolism: Patients with high BMI benefit considerably

2014-12-05
Apixaban (trade name Eliquis) has been approved since July 2014 for acute treatment of adults with deep vein thrombosis or pulmonary embolism. In addition, the drug can be used for low-dose long-term treatment to prevent recurrent thrombosis or pulmonary embolism. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether in these cases the drug offers patients an added benefit over the appropriate comparator therapies. According to the findings, considerable added benefit of apixaban is proven for the initial treatment ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

State gun laws and firearm-related homicides and suicides

Use of tobacco and cannabis following state-level cannabis legalization

Long-term obesity and biological aging in young adults

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

[Press-News.org] Screening for matrix effect in leukemia subtypes could sharpen chemotherapy targeting